🇺🇸 FDA
Patent

US 7943141

Activated polyoxazolines and compositions comprising the same

granted A61KA61K31/787A61K47/60

Quick answer

US patent 7943141 (Activated polyoxazolines and compositions comprising the same) held by Serina Therapeutics, Inc. expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/787, A61K47/60